会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 21. 发明授权
    • Production of plasminogen activator
    • 生产纤溶酶原激活物
    • US4317882A
    • 1982-03-02
    • US143680
    • 1980-04-25
    • Sadayuki HoriguchiAkio HasegawaMitsuru Shibukawa
    • Sadayuki HoriguchiAkio HasegawaMitsuru Shibukawa
    • A61K38/00C12N9/72C12N9/48
    • C12N9/6462C12Y304/21073A61K38/00Y10S435/818
    • A plasminogen activator having a molecular weight of 45,000 to 68,000 is formed as a single fraction in the cells of human kidney or lung, and is separated and recovered with good efficiency without reducing its molecular weight. The pH of a solution to be contacted with said cells and the concentration of dissolved oxygen should be maintained within suitable ranges in order to form the plasminogen activator having a molecular weight of 45,000 to 68,000 as a single fraction. Furthermore, by properly adjusting the residence time of the solution with the cells, the activator can be formed over a long period of more than 40 days. To separate the activator, the pH of the solution in the separating step is maintained preferably at 4 to 12. By causing a metal chelating agent to be present in the solution in the separating step, the plasminogen activator can be obtained without reducing its molecular weight.
    • 在人肾或肺细胞中形成分子量为45,000至68,000的纤溶酶原激活剂作为单一部分,并且在不降低其分子量的情况下以高效率分离和回收。 要与所述细胞接触的溶液的pH值和溶解氧的浓度应保持在合适的范围内,以形成分子量为45,000至68,000的纤溶酶原激活剂作为单一部分。 此外,通过适当调整溶液与细胞的停留时间,可以在40天以上的长时间内形成活化剂。 为了分离活化剂,分离步骤中的溶液的pH优选保持在4至12.通过在分离步骤中使溶液中存在金属螯合剂,可以在不降低其分子量的情况下获得纤溶酶原激活剂 。